Bioabsorbable Stents Market
Bioabsorbable Stents Market Size, Share & Trends Analysis Report by Polymer Type (Poly (L-Lactic Acid) PLLA, Tyrosine Polycarbonate Polymer, Poly (Caprolactone) (PCL), Poly (Anhydride Ester) Salicylic Acid) By Application (Coronary Artery Diseases, Peripheral Artery Diseases, and others) By End-User (Hospitals, Cardiac Centers, and Others), Forecast Period (2026-2035)
Industry Overview
Bioabsorbable stents market was valued at $150.3 million in 2025 and is projected to reach $242.9 million by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035). The global bioabsorbable materials market is advancing as healthcare systems place greater emphasis on devices that minimize long-term complications and reduce the need for secondary procedures. Growing clinical confidence in these materials has encouraged wider adoption across cardiovascular, orthopedic, and wound-care applications. At the same time, steady improvements in polymer engineering and manufacturing precision have enhanced product reliability and broadened their medical uses. Increased investment from both established firms and emerging developers is also helping accelerate innovation in this field. As regulatory bodies refine pathways for novel bioabsorbable technologies, market participation continues to expand.
Market Dynamics
Broader Clinical Integration of Bioabsorbable Technologies
The global bioabsorbable market is benefiting from wider clinical acceptance, as physicians increasingly prioritize materials that dissolve naturally and avoid long-term device retention. Adoption is rising across cardiovascular, orthopaedic, and tissue-regeneration segments, driven by steady improvements in device performance and predictable degradation profiles. Hospitals and specialty clinics are gradually incorporating these solutions into standard treatment pathways, supporting consistent demand. As more clinical data validate long-term safety outcomes, the market is seeing stronger confidence among practitioners and patients alike. This shift toward temporary, physiologically compatible devices continues to anchor the market’s upward momentum.
Advancements in Polymer Science and Manufacturing Precision
Progress in polymer chemistry and bioengineering is enabling the development of materials with tailored strength, controlled resorption, and improved biocompatibility. These enhancements have expanded the functional scope of bioabsorbable products, making them suitable for increasingly complex procedures. Manufacturers are adopting more refined processing methods, allowing for better consistency and structural integrity of finished devices. The resulting improvements have encouraged greater investment from industry players seeking to differentiate through material innovation.
Market Segmentation
- Based on the polymer type, the market is segmented into poly (L-Lactic Acid) PLLA, tyrosine polycarbonate polymer, poly (Caprolactone) (PCL), and poly (Anhydride Ester) salicylic acid.
- Based on the application, the market is segmented into coronary artery diseases, peripheral artery diseases, and others.
- Based on the end-user, the market is segmented into hospitals, research centers, cardiac centers, and others.
Polymer Segment to Lead the Market with the Largest Share
The global market for bioabsorbable stents is gaining momentum as advances in polymer technology improve the reliability and performance of these devices. Refined polymer structures now offer greater strength, predictable degradation, and improved compatibility with surrounding tissues. These developments have encouraged broader clinical use, particularly in procedures where temporary vascular support is preferred. Manufacturers are also investing in polymer formulations that allow more precise control over absorption timelines, strengthening confidence among physicians. As these materials become more sophisticated, they are helping shape new standards in minimally invasive cardiovascular care.
Coronary Artery Disease: A Key Segment in Market Growth
The global bioabsorbable market is expanding as the need for advanced treatment options in coronary artery disease continues to rise. Physicians are increasingly turning to temporary, resorbable devices that provide essential vascular support without leaving a permanent implant behind. This approach aligns well with evolving clinical preferences for therapies that reduce long-term complications and simplify future interventions. As patient volumes grow and diagnostic capabilities improve, demand for bioabsorbable solutions in coronary care has strengthened noticeably. Expanded research activity and broader clinical adoption are further reinforcing this trend.
Regional Outlook
The global bioabsorbable stent market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Growing Adoption of Resorbable Devices in Europe
The bioabsorbable stent market in Europe is advancing as healthcare systems place greater emphasis on treatment options that minimize long-term implant presence. Clinical teams are increasingly adopting resorbable devices to support procedures where vessel healing and future intervention flexibility are priorities. Regulatory clarity and well-defined evaluation standards in the region have also encouraged broader adoption of these technologies. At the same time, hospitals and specialty centers are incorporating updated cardiovascular protocols that favor temporary scaffolding solutions. Continued investment in clinical research and product refinement is further reinforcing this momentum.
North America Region Dominates the Market with Major Share
The bioabsorbable market in North America is gaining traction as healthcare providers place increasing value on devices that support healing without remaining permanently in the body. Clinical practitioners are integrating these solutions into cardiovascular care pathways where temporary structural support is preferred. Improved patient screening and wider access to advanced diagnostic tools have further supported their use in appropriate cases. Ongoing evaluations by regional medical institutions have also strengthened confidence in the performance of these materials. In addition, steady investment in research and commercialization is encouraging broader availability across major healthcare networks.
Market Players Outlook
The major companies operating in the global bioabsorbable stent market include Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., MicroPort Scientific Corp., and Terumo Corp., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In April 2024, the U.S. FDA approved Abbott’s Esprit BTK everolimus-eluting resorbable scaffold system for patients with chronic limb-threatening ischemia affecting below-the-knee arteries. This bioresorbable, drug-eluting scaffold opens blocked arteries, delivers everolimus to support vessel healing, and gradually dissolves, leaving no permanent implant.
- In July 2024, MicroPort Scientific Corporation’s fully owned subsidiary Shanghai MicroPort Medical (Group) Co., Ltd. got approval from the National Medical Products Administration (NMPA) for ‘Firesorb’, which is a fully bioresorbable cardiac stent.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global bioabsorbable stent market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Bioabsorbable Stents Market Sales Analysis – Polymer Type| Application | End-User| ($ Million)
- Bioabsorbable Stents Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Bioabsorbable Stents Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Bioabsorbable Stents Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Bioabsorbable Stents Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Bioabsorbable Stents Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Bioabsorbable Stents Market Revenue and Share by Manufacturers
- Bioabsorbable Stents Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Boston Scientific Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- MicroPort Scientific Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Terumo Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global Bioabsorbable Stents Market Sales Analysis by Polymer Type ($ Million)
- Poly (L-Lactic Acid) PLLA
- Tyrosine Polycarbonate Polymer
- Poly (Caprolactone) (PCL)
- Poly (Anhydride Ester) Salicylic Acid)
- Global Bioabsorbable Stents Market Sales Analysis by Application ($ Million)
- Coronary Artery Disease
- Peripheral Artery Diseases
- Others
- Global Bioabsorbable Stents Market Sales Analysis by End-User ($ Million)
- Hospitals
- Cardiac Centers
- Others
- Regional Analysis
- North American Bioabsorbable Stents Market Sales Analysis – Polymer Type| Application | End-User| Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Bioabsorbable Stents Market Sales Analysis – Polymer Type| Application| End-User| Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Bioabsorbable Stents Market Sales Analysis – Polymer Type| Application| End-User| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Bioabsorbable Stents Market Sales Analysis – Polymer Type| Application| End-User| Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ALVIMEDICA TIBBI URUNLER SANAYI VE DIS TICARET ANONIM SIRKETI
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Arterius Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biosensors International Group, Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardionovum GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Elixir Medical Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kyoto Medical Planning Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LEPU Medical Technology (Beijing) Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Meril Life Sciences Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort Scientific Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- REVA Medical, LLC.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- S3V Vascular Technologies Pvt.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sino Medical Sciences Technology Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- STENTiT B.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teleflex Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zorion Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global Bioabsorbable Stents Market Research and Analysis by Polymer Type, 2025-2035 ($ million)
2. Global Poly (L-Lactic Acid) PLLA-Based Bioabsorbable Stents Market Research and Analysis by Region, 2025-2035 ($ million)
3. Global Tyrosine Polycarbonate Polymer-Based Bioabsorbable Stents Market Research and Analysis by Region, 2025-2035 ($ million)
4. Global Poly(Caprolactone) (PCL) Based Bioabsorbable Stents Market Research and Analysis by Region, 2025-2035 ($ million)
5. Global Poly (Anhydride Ester) Salicylic Acid-Based Bioabsorbable Stents Market Research and Analysis by Drugs, 2025-2035 ($ million)
6. Global Bioabsorbable Stents Market Research and Analysis by Application, 2025-2035 ($ million)
7. Global Bioabsorbable Stents For Coronary Artery Diseases Market Research And Analysis By Region, 2025-2035 ($ Million)
8. Global Bioabsorbable Stents For Peripheral Artery Diseases Market Research And Analysis By Region, 2025-2035 ($ Million)
9. Global Bioabsorbable Stents Market Research and Analysis by End-User, 2025-2035 ($ million)
10. Global Bioabsorbable Stents In Hospitals Market Research and Analysis by Region, 2025-2035 ($ million)
11. Global Bioabsorbable Stents In Cardiac Centers Market Research and Analysis by Region 2025-2035 ($ million)
12. Global Bioabsorbable Stents In Other End-User Market Research and Analysis by Region 2025-2035 ($ million)
13. Global Bioabsorbable Stents Market Research and Analysis by Region, 2025-2035 ($ million)
14. North American Bioabsorbable Stents Market Research and Analysis by Country, 2025-2035 ($ million)
15. North American Bioabsorbable Stents Market Research and Analysis by Polymer Type, 2025-2035 ($ million)
16. North American Bioabsorbable Stents Market Research and Analysis by Application, 2025-2035 ($ million)
17. North American Bioabsorbable Stents Market Research and Analysis by End-User, 2025-2035 ($ million)
18. European Bioabsorbable Stents Market Research and Analysis by Country, 2025-2035 ($ million)
19. European Bioabsorbable Stents Market Research and Analysis by Polymer Type, 2025-2035 ($ million)
20. European Bioabsorbable Stents Market Research and Analysis by Application, 2025-2035 ($ million)
21. European Bioabsorbable Stents Market Research and Analysis by End-User, 2025-2035 ($ million)
22. Asia-Pacific Bioabsorbable Stents Market Research and Analysis by Country, 2025-2035 ($ million)
23. Asia-Pacific Bioabsorbable Stents Market Research and Analysis by Polymer Type, 2025-2035 ($ million)
24. Asia-Pacific Bioabsorbable Stents Market Research and Analysis by Application, 2025-2035 ($ million)
25. Asia-Pacific Bioabsorbable Stents Market Research and Analysis by End-User, 2025-2035 ($ million)
26. Rest of The World Bioabsorbable Stents Market Research and Analysis by Country, 2025-2035 ($ million)
27. Rest of The World Bioabsorbable Stents Market Research and Analysis by Polymer Type 2025-2035 ($ million)
28. Rest of The World Bioabsorbable Stents Market Research and Analysis by Application, 2025-2035 ($ million)
29. Rest of The World Bioabsorbable Stents Market Research and Analysis by End-User, 2025-2035 ($ million)
1. Global Bioabsorbable Stents Market Share by Components, 2025 Vs 2035 (%)
2. Global Poly (L-Lactic Acid) PLLA-Based Bioabsorbable Stents Market Share by Region, 2025 Vs 2035 (%)
3. Global Tyrosine Polycarbonate Polymer-Based Bioabsorbable Stents Market Share by Region, 2025 Vs 2035 (%)
4. Global Poly (Caprolactone) (PCL) Based Bioabsorbable Stents Market Share by Region, 2025 Vs 2035 (%)
5. Globa Poly (Anhydride Ester) Salicylic Acid-Based Bioabsorbable Stents Market Share by Region, 2025 Vs 2035 (%)
6. Global Bioabsorbable Stents Market Share by Application, 2025 Vs 2035 (%)
7. Global Bioabsorbable Stents For Coronary Artery Diseases Market Share by Region, 2025 Vs 2035 (%)
8. Global Bioabsorbable Stents For Peripheral Artery Diseases Market Share by Region, 2025 Vs 2035 (%)
9. Global Bioabsorbable Stents Market Share by End-User, 2025 Vs 2035 (%)
10. Global Bioabsorbable Stents In Hospitals Market Share by Region, 2025 Vs 2035 (%)
11. Global Bioabsorbable Stents In Cardiac Centers Market Share by Region, 2025 Vs 2035 (%)
12. Global Bioabsorbable Stents In Other End-User Market Share by Region, 2025 Vs 2035 (%)
13. Global Bioabsorbable Stents Market Research and Analysis by Region, 2025–2035 ($ Million)
14. US Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
15. Canada Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
16. UK Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
17. France Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
18. Germany Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
19. Italy Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
20. Spain Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
21. Russia Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
22. Rest of Europe Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
23. India Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
24. China Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
25. Japan Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
26. South Korea Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
27. Australia and New Zealand Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
28. ASEAN Economies Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
29. Rest of Asia-Pacific Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
30. Latin America Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
31. Middle East and Africa Bioabsorbable Stents Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Bioabsorbable Stents Market in 2025 is estimated to be around $150.3 million.
North America holds the largest share in the Bioabsorbable Stents Market.
Leading players in the Bioabsorbable Stents Market include Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., MicroPort Scientific Corp., and Terumo Corp., among others.
Bioabsorbable Stents Market is expected to grow at a CAGR of 5.0% from 2026 to 2035.
The bioabsorbable stents market is growing due to rising cardiovascular disease incidence, preference for minimally invasive procedures, and advancements in biodegradable stent technologies.
